Cargando…

Personalized Medicine in Cardiovascular Diseases

Personalized medicine is a novel medical model with all decisions and practices being tailored to individual patients in whatever ways possible. In the era of genomics, personalized medicine combines the genetic information for additional benefit in preventive and therapeutic strategies. Personalize...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Moo-Sik, Flammer, Andreas J., Lerman, Lilach O., Lerman, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467440/
https://www.ncbi.nlm.nih.gov/pubmed/23091501
http://dx.doi.org/10.4070/kcj.2012.42.9.583
_version_ 1782245804222709760
author Lee, Moo-Sik
Flammer, Andreas J.
Lerman, Lilach O.
Lerman, Amir
author_facet Lee, Moo-Sik
Flammer, Andreas J.
Lerman, Lilach O.
Lerman, Amir
author_sort Lee, Moo-Sik
collection PubMed
description Personalized medicine is a novel medical model with all decisions and practices being tailored to individual patients in whatever ways possible. In the era of genomics, personalized medicine combines the genetic information for additional benefit in preventive and therapeutic strategies. Personalized medicine may allow the physician to provide a better therapy for patients in terms of efficiency, safety and treatment length to reduce the associated costs. There was a remarkable growth in scientific publication on personalized medicine within the past few years in the cardiovascular field. However, so far, only very few cardiologists in the USA are incorporating personalized medicine into clinical treatment. We review the concepts, strengths, limitations and challenges of personalized medicine with a particular focus on cardiovascular diseases (CVDs). There are many challenges from both scientific and policy perspectives to personalized medicine, which can overcome them by comprehensive concept and understanding, clinical application, and evidence based practices. Individualized medicine serves a pivotal role in the evolution of national and global healthcare reform, especially, in the CVDs fields. Ultimately, personalized medicine will affect the entire landscape of health care system in the near future.
format Online
Article
Text
id pubmed-3467440
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-34674402012-10-22 Personalized Medicine in Cardiovascular Diseases Lee, Moo-Sik Flammer, Andreas J. Lerman, Lilach O. Lerman, Amir Korean Circ J Review Personalized medicine is a novel medical model with all decisions and practices being tailored to individual patients in whatever ways possible. In the era of genomics, personalized medicine combines the genetic information for additional benefit in preventive and therapeutic strategies. Personalized medicine may allow the physician to provide a better therapy for patients in terms of efficiency, safety and treatment length to reduce the associated costs. There was a remarkable growth in scientific publication on personalized medicine within the past few years in the cardiovascular field. However, so far, only very few cardiologists in the USA are incorporating personalized medicine into clinical treatment. We review the concepts, strengths, limitations and challenges of personalized medicine with a particular focus on cardiovascular diseases (CVDs). There are many challenges from both scientific and policy perspectives to personalized medicine, which can overcome them by comprehensive concept and understanding, clinical application, and evidence based practices. Individualized medicine serves a pivotal role in the evolution of national and global healthcare reform, especially, in the CVDs fields. Ultimately, personalized medicine will affect the entire landscape of health care system in the near future. The Korean Society of Cardiology 2012-09 2012-09-27 /pmc/articles/PMC3467440/ /pubmed/23091501 http://dx.doi.org/10.4070/kcj.2012.42.9.583 Text en Copyright © 2012 The Korean Society of Cardiology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Lee, Moo-Sik
Flammer, Andreas J.
Lerman, Lilach O.
Lerman, Amir
Personalized Medicine in Cardiovascular Diseases
title Personalized Medicine in Cardiovascular Diseases
title_full Personalized Medicine in Cardiovascular Diseases
title_fullStr Personalized Medicine in Cardiovascular Diseases
title_full_unstemmed Personalized Medicine in Cardiovascular Diseases
title_short Personalized Medicine in Cardiovascular Diseases
title_sort personalized medicine in cardiovascular diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467440/
https://www.ncbi.nlm.nih.gov/pubmed/23091501
http://dx.doi.org/10.4070/kcj.2012.42.9.583
work_keys_str_mv AT leemoosik personalizedmedicineincardiovasculardiseases
AT flammerandreasj personalizedmedicineincardiovasculardiseases
AT lermanlilacho personalizedmedicineincardiovasculardiseases
AT lermanamir personalizedmedicineincardiovasculardiseases